Breast Cancer Research and Treatment

, Volume 98, Issue 3, pp 303–309

Increased prevalence of prior breast cancer in women with newly diagnosed diabetes

  • Lorraine L. Lipscombe
  • Pamela J. Goodwin
  • Bernard Zinman
  • John R. McLaughlin
  • Janet E. Hux
Epidemiology

DOI: 10.1007/s10549-006-9166-3

Cite this article as:
Lipscombe, L.L., Goodwin, P.J., Zinman, B. et al. Breast Cancer Res Treat (2006) 98: 303. doi:10.1007/s10549-006-9166-3

Summary

Objective

There is growing evidence of a link between type 2 diabetes and breast cancer, possibly through insulin resistance and/or hyperinsulinemia. Because insulin levels are at their highest prior to the development of diabetes, breast cancer risk may be even greater during the pre-diabetes period.

Research design and methods

In this cross-sectional study, women aged 55–79 years living in Ontario, Canada, with newly diagnosed diabetes from 1994 to 2002 were identified from a validated, population-based database (N = 82,390). Prior history of breast cancer in this group was recorded from 1964 until their diabetes diagnosis from a linkable cancer registry, and was compared to a similarly aged comparison group without diabetes (N = 411,950).

Results

Prior breast cancers were identified in 3.7% of women with diabetes and in 3.1% women without diabetes (odds ratio, OR 1.22, 95% confidence interval, CI 1.17–1.27, p < 0.0001). The mean time from breast cancer diagnosis to diabetes diagnosis was 7.9 years. The likelihood of a breast cancer history remained significantly higher in women with diabetes after adjustment for age, income and physician visits (OR 1.13, 95% CI 1.09–1.18, p < 0.0001).

Conclusions

These results suggest that breast cancer risk may be increased in the pre-diabetes phase and may have implications for screening and prevention strategies. Further studies are required to better characterize the processes that link insulin resistance, diabetes and breast cancer.

Keywords

breast cancer diabetes epidemiology insulin resistance pre-diabetes prevalence 
Download to read the full article text

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Lorraine L. Lipscombe
    • 1
    • 2
    • 4
    • 7
  • Pamela J. Goodwin
    • 2
    • 3
    • 5
    • 6
  • Bernard Zinman
    • 2
    • 5
    • 6
  • John R. McLaughlin
    • 3
    • 6
  • Janet E. Hux
    • 1
    • 2
    • 3
    • 4
  1. 1.Institute for Clinical Evaluative SciencesTorontoCanada
  2. 2.Department of MedicineUniversity of TorontoTorontoCanada
  3. 3.Department of Health Policy, Management and EvaluationUniversity of TorontoTorontoCanada
  4. 4.Sunnybrook and Women’s College Health Sciences CentreTorontoCanada
  5. 5.Mount Sinai HospitalTorontoCanada
  6. 6.Samuel Lunenfeld Research InstituteTorontoCanada
  7. 7.Institute for Clinical Evaluative SciencesTorontoCanada

Personalised recommendations